Michael Taylor

418 total citations
11 papers, 271 citations indexed

About

Michael Taylor is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Taylor has authored 11 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Taylor's work include Advanced Breast Cancer Therapies (2 papers), Colorectal and Anal Carcinomas (2 papers) and Cancer-related Molecular Pathways (2 papers). Michael Taylor is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Colorectal and Anal Carcinomas (2 papers) and Cancer-related Molecular Pathways (2 papers). Michael Taylor collaborates with scholars based in United States, Australia and Canada. Michael Taylor's co-authors include A.D. DePetrillo, A. Robert Turner, Lloyd H. Smith, Walter Kinney, Sidney Scudder, Anthony H. Russell, John D. Trelford, Gary S. Leiserowitz, J Mesić and Jay C. Strum and has published in prestigious journals such as Cancer, Cancer Research and Cancer Discovery.

In The Last Decade

Michael Taylor

11 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Taylor United States 8 135 75 72 69 60 11 271
G.K. Rath India 9 147 1.1× 93 1.2× 64 0.9× 110 1.6× 86 1.4× 34 339
Alan K. Muñoz United States 10 143 1.1× 124 1.7× 47 0.7× 59 0.9× 45 0.8× 12 332
Swee Peng Yap Singapore 11 96 0.7× 60 0.8× 38 0.5× 78 1.1× 187 3.1× 23 372
Maliheh Arab Iran 12 72 0.5× 102 1.4× 78 1.1× 27 0.4× 105 1.8× 79 371
Stephen S. Falkenberry United States 10 83 0.6× 174 2.3× 68 0.9× 77 1.1× 53 0.9× 12 316
Eun Young Ki South Korea 12 171 1.3× 138 1.8× 145 2.0× 46 0.7× 122 2.0× 29 414
Susan S. Devesa United States 7 60 0.4× 49 0.7× 129 1.8× 49 0.7× 188 3.1× 8 392
Betty Pras Netherlands 5 65 0.5× 186 2.5× 66 0.9× 39 0.6× 49 0.8× 6 273
G.R. Kerr United Kingdom 10 98 0.7× 89 1.2× 46 0.6× 55 0.8× 85 1.4× 15 271
G. Barker United Kingdom 10 122 0.9× 77 1.0× 38 0.5× 80 1.2× 115 1.9× 17 382

Countries citing papers authored by Michael Taylor

Since Specialization
Citations

This map shows the geographic impact of Michael Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Taylor more than expected).

Fields of papers citing papers by Michael Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Taylor. The network helps show where Michael Taylor may publish in the future.

Co-authorship network of co-authors of Michael Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Taylor. A scholar is included among the top collaborators of Michael Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Taylor. Michael Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ahn, Antonio, Michael Taylor, Keefe T. Chan, et al.. (2023). INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors. Cancer Discovery. 14(3). 446–467. 62 indexed citations
2.
Bisi, John, et al.. (2023). Abstract 5994: INX-315, a potent and selective CDK2 inhibitor, demonstrates robust antitumor activity in CCNE1-amplified cancers. Cancer Research. 83(7_Supplement). 5994–5994. 4 indexed citations
4.
O’Connor, Ellen, Jonathon J. O’Brien, Michael Taylor, et al.. (2020). Future directions in advanced penile cancer – mechanisms of carcinogenesis and a search for targeted therapy. Future Oncology. 16(29). 2357–2369. 8 indexed citations
5.
Taylor, Michael. (2020). Why is there a shortage of doctors in the UK?. Bulletin of The Royal College of Surgeons of England. 102(3). 78–81. 27 indexed citations
6.
Taylor, Michael, Eric E. Schmidt, Jeremy Morris, et al.. (2000). Lymph node metastasis in malignant melanoma: an in vivo animal model.. PubMed. 29(4). 233–8. 1 indexed citations
7.
Leiserowitz, Gary S., Anthony H. Russell, Walter Kinney, et al.. (1997). Prophylactic Chemoradiation of Inguinofemoral Lymph Nodes in Patients with Locally Extensive Vulvar Cancer. Gynecologic Oncology. 66(3). 509–514. 32 indexed citations
8.
Krag, David N., Michael K. Haseman, Patrick V. Ford, et al.. (1992). Gamma probe location of 111 indium‐labeled B72.3: An extension of immunoscintigraphy. Journal of Surgical Oncology. 51(4). 226–230. 16 indexed citations
9.
Russell, Anthony H., J Mesić, Sidney Scudder, et al.. (1992). Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecologic Oncology. 47(1). 14–20. 56 indexed citations
10.
Qizilbash, Ali H., et al.. (1985). Adenocarcinoma in a cecal neovagina—Complication of irradiation: Report of a case and review of literature. Gynecologic Oncology. 21(2). 235–239. 14 indexed citations
11.
Taylor, Michael, A.D. DePetrillo, & A. Robert Turner. (1985). Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer. 56(6). 1341–1349. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026